RVL Pharmaceuticals PLC (RVLPQ)
0.0005
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
RVL Pharmaceuticals Debt to Equity Ratio: 3.537 for June 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | 3.537 |
| March 31, 2023 | 1.430 |
| December 31, 2022 | 1.114 |
| September 30, 2022 | 0.8155 |
| June 30, 2022 | 0.7436 |
| March 31, 2022 | 0.6708 |
| December 31, 2021 | 0.6022 |
| September 30, 2021 | 0.5466 |
| June 30, 2021 | 3.137 |
| March 31, 2021 | 2.579 |
| December 31, 2020 | 2.339 |
| September 30, 2020 | 1.455 |
| Date | Value |
|---|---|
| June 30, 2020 | 2.051 |
| March 31, 2020 | 1.866 |
| December 31, 2019 | 2.336 |
| September 30, 2019 | 1.892 |
| June 30, 2019 | 1.040 |
| March 31, 2019 | 0.7026 |
| December 31, 2018 | 0.6997 |
| September 30, 2018 | 0.7607 |
| June 30, 2018 | 0.758 |
| March 31, 2018 | |
| December 31, 2017 | 0.7357 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5466
Minimum
Sep 2021
3.537
Maximum
Jun 2023
1.656
Average
1.455
Median
Sep 2020
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 85.40M |
| Total Liabilities (Quarterly) | 69.08M |
| Shareholders Equity (Quarterly) | 16.33M |
| Current Ratio | 0.3765 |
| Net Debt Paydown Yield | -4.00% |